Effectiveness of animal-assisted therapy in adolescent psychiatric inpatients: a multicenter clinical trial
摘要
The number of adolescents hospitalized with mental health problems, which are vulnerable and under a stressful situation, has increased in the last years. Non-pharmacological therapies, including Animal Assisted Therapy (AAT), have been proposed as complementary approaches to current psychiatric interventions and contribute to the comprehensive care of patient; however, current studies are inconclusive and further studies are recommended. This study aimed to evaluate the efficacy of AAT in improving self-efficacy and reducing anxiety symptoms among adolescents in acute psychiatric units, assess healthcare professionals’ perceptions, and determine participant satisfaction.
MethodsA multicenter, non-randomized clinical trial was conducted in the Acute Child and Adolescent Psychiatry Unit from three Hospitals. The Control Group (CG) had 1 session 1 h per week, and the Experimental Group (EG) also had 1 session 1 h per week with the additional assistance of the therapy dog, during 2 weeks. We used the General Self-Efficacy Scale and State-Trait Anxiety Inventory Questionnaire (STAI) before and after the intervention, and collected the Participant’s satisfaction post intervention.
ResultsA total of 178 participants were included in the study (64 CG and 114 EG). A significant improvement in self-efficacy was obtained in the EG compared to the CG. And a statistically significant improvement in anxiety (STAI-State) was observed in the EG, but the difference was not significant when comparing both groups. Participants reported a high level of satisfaction with the intervention.
ConclusionsOur findings suggest that AAT may improve self-efficacy in adolescents with psychiatric conditions. However, no significant differences were observed between groups regarding anxiety levels. This study aims to provide innovation and research in a little studied area that may be useful as a complement to pharmacological treatment in the adolescent population. The clinical trial was retrospectively registered in the “Clinical Trials.gov”, registration number: NCT06414850 (05/16/2024).